Clinical trial
Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)
NCT00395603 · Organon and Co, Industry · Terminated
Key facts
| NCT number | NCT00395603 |
|---|---|
| Title | Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122) |
| Official title | Compare Ezetimibe 10mg and Simvastatin 40mg vs Atorvastatin 80mg Daily in Subjects With Cardiovascular Heart Disease and/or Diabetes Mellitus With Uncontrolled Lipids on Statin Therapy |
| Lead sponsor | Organon and Co, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks, Comparator: atorvastatin / Duration of Treatment: 6 Weeks |
| Enrollment | 550 |
| Start date | Sep 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Nov 3, 2006 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: